Iski Gabriella, Rurik Sarolta E, Rurik Imre
Faculty of Public health, Department of Family and Occupational Medicine, University of Debrecen, Debrecen, Hungary.
Independent macroeconomic adviser.
Exp Clin Endocrinol Diabetes. 2019 Jan;127(1):62-67. doi: 10.1055/a-0630-0318. Epub 2018 Jul 2.
Obesity could be considered as the main consequence of unhealthy nutrition, responsible for many pathological alterations in human. Obese patients usually need more health care services. The aim of the study was to estimate the financial expenditures of health care provisions in Hungary, related to obesity and diabetes, as its main pathological consequence.
Data of the Hungarian National Health Insurance Fund (NHIF) were collected for 2013, regarding finances of secondary care, hospital services, reimbursement for medications and healing aids of diabetic patients together with selected morbidities linked to obesity, based on the codes of the International Classification of Diseases (ICD) and calculated their population prevalence on the population-attributable fraction (PAF).
Financial data regarding diabetes care resulted in a 40,311 Million HUF (129 Million EUR) national fund expenses, beside a 7,173 Million HUF (23 Million EUR) contribution from patients. Estimated total health care expenditures related to obesity were 58,986 Million HUF (188 Million EUR) and the financial contribution of patients was calculated as 25,316 Million HUF (81 Million EUR). These data represent a 5.2% and 9.3% of the whole national health services, 16% and 30% of the whole drug-reimbursement budgets, respectively.
Although expenditures for some obesity related pathologies analyzed in this paper represent 0.28% of the national GDP, considering other morbidities and other patient's expenses, the real ratio could be between 0.5-1%. The increasing number of overweight and obese persons requires more focus in public health, higher awareness in the society and more governmental support.
肥胖可被视为不健康营养的主要后果,它会导致人体出现许多病理改变。肥胖患者通常需要更多的医疗保健服务。本研究的目的是估算匈牙利与肥胖及其主要病理后果糖尿病相关的医疗保健支出。
收集了匈牙利国家健康保险基金(NHIF)2013年的数据,这些数据涉及二级医疗保健、医院服务、糖尿病患者药物和治疗辅助器具的报销费用,以及与肥胖相关的特定疾病,这些数据基于国际疾病分类(ICD)编码,并计算了它们在人群归因分数(PAF)上的人群患病率。
糖尿病护理的财务数据显示,国家基金支出为403.11亿匈牙利福林(1.29亿欧元),此外患者还贡献了71.73亿匈牙利福林(2300万欧元)。与肥胖相关的估计医疗保健总支出为589.86亿匈牙利福林(1.88亿欧元),患者的财务贡献计算为253.16亿匈牙利福林(8100万欧元)。这些数据分别占全国医疗服务的5.2%和9.3%,占整个药物报销预算的16%和30%。
尽管本文分析的一些与肥胖相关疾病的支出占国家GDP的0.28%,但考虑到其他疾病和患者的其他费用,实际比例可能在0.5%-1%之间。超重和肥胖人群数量的增加需要公共卫生更多关注、社会更高的认识以及政府更多的支持。